Skip to content

REGENERX BIOPHARMACEUTICALS, INC.

CIK 0000707511

← back to feed
Revenue (TTM)
$76.76K
0.0% YoY Q1 May 2023
Net Income (TTM)
−$1.72M
−8.1% YoY Q1 May 2023
EPS Diluted (TTM)
$0.00
0.0% YoY Q1 May 2023
Gross Margin
67.4%
Q1 May 2023
Operating Margin
-1,821.3%
Q1 May 2023
Net Margin
-2,243.0%
Q1 May 2023
Free Cash Flow (TTM)
−$1.01M
Q1 May 2023
Cash
$101.56K
Q1 May 2023
Total Debt
—
Q1 May 2023
Shares Outstanding
143.55M sh
Q1 May 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings